Accessibility Menu
CYduct Diagnostics logo

CYduct Diagnostics(OTC) CYDX

Current Price$2.70
Market Cap$13.88MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2007)-100%
5 Year+1,074%
1 Year+971%
1 Month+570%
CYduct Diagnostics last closing stock price
MetricPriceDate
Last closeUSD 2.702026-07-21
CYduct Diagnostics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-4.93%USD 2.842026-07-14
1 month+569.98%USD 0.402026-06-17
3 month+342.62%USD 0.612026-04-22
Year to date+1,229.39%USD 0.202025-12-31
1 year+971%USD 0.252025-07-17
3 year+499.87%USD 0.452023-07-21
5 year+1,073.91%USD 0.232021-07-20
Since inception-100%USD 15,151,515,151.522007-01-16

CYduct Diagnostics Financials at a Glance

Market Cap

$13.88MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$65.69K

Net Income (TTM)

-$349.60K

EPS (TTM)

-$0.07

P/E Ratio

-40.48

Dividend

$0.00

Beta (Volatility)

-0.02 (Low)

Price

$2.70

Volume

1

Open

$2.70

Previous Close

$2.70

Daily Range

$2.70 - $2.70

52-Week Range

$0.20 - $2.90

Estimated Earnings Date

N/A

CYDX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About CYduct Diagnostics

CYduct Diagnostics, Inc. is a medical instrument company focused on engineering and commercializing innovative technologies for health diagnostics and therapeutic interventions. Established in 1986 and headquartered in Westport, Connecticut, the company offers a diverse range of medical devices and methodologies aimed at improving patient care.

Products and Services
  • Specialized breast endoscopy systems for enhanced diagnostic capabilities
  • Comprehensive range of endoscopic instruments and surgical tools
  • Illumination products including fiber optic cables and light sources
Growth Outlook
  • Recent quarterly revenue increased to $22,997, reflecting a strong demand for medical devices
  • Gross profit margin improved to 50.96% in the latest quarter, indicating operational efficiency
  • Continued investment in product development positions the company for future growth
Financial Highlights
  • Trailing twelve months (TTM) revenue of $93,262, showcasing a steady revenue stream
  • Net income for the latest quarter was -$79,457, indicating ongoing investment in growth
  • Cash at the end of the latest quarter was $8,976, providing liquidity for operations
CYduct Diagnostics, Inc. operates in the medical devices sector, providing essential tools for healthcare professionals. The company’s product offerings are designed to meet the needs of various surgical specialties, enhancing diagnostic accuracy and patient outcomes. Recent financial performance indicates a positive trajectory, with increasing revenue and improving gross profit margins. The company’s focus on innovation and product development is expected to drive future growth, making it a noteworthy consideration for investors interested in the healthcare sector.
AI Generated • Jul 8, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

Dominick L. Gatto

Website

www.cyductdx.com

Headquarters

Westport, CT 06880, US

CYDX Financials

Key Financial Metrics (TTM)

Gross Margin

60.66%

Operating Margin

-458.90%

Net Income Margin

-532.19%

Return on Equity

11.90%

Return on Capital

N/A

Return on Assets

-1411.74%

Earnings Yield

-2.47%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$13.88MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

5.14M

Volume

1

Avg. Volume

2.35K

Financials (TTM)

Gross Profit

$39.85K

Operating Income

-$301.45K

EBITDA

-$297.68K

Operating Cash Flow

$10.30K

Capital Expenditure

-$4.00

Free Cash Flow

$10.29K

Cash & ST Invst.

$8.98K

Total Debt

$709.29K

CYduct Diagnostics Performance Analysis

CYduct Diagnostics annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30USD 94,054N/A
20232023-06-30USD 119,33926.9%
20242024-06-30USD 84,484-29.2%
20252025-06-30USD 70,687-16.3%
CYduct Diagnostics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-06-3045.5%
Q12025-09-30-61.6%
Q22025-12-310.4%
Q32026-03-31147.3%
CYduct Diagnostics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30USD -0.08N/A
20232023-06-30USD -0.0913.2%
20242024-06-30USD -0.08-13.3%
20252025-06-30USD -0.08-1.7%
CYduct Diagnostics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-06-3015.7%
Q12025-09-303.8%
Q22025-12-319.1%
Q32026-03-314.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$23.00K

+38.7%

Gross Profit

$11.72K

+7.3%

Gross Margin

50.96%

N/A

Market Cap

$13.88MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$4.63M

N/A

Employees

3

N/A

Net Income

-$79.46K

+29.7%

EBITDA

-$66.51K

+33.6%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Total Cash

$8.98K

+117.9%

Total Debt

$709.29K

-0.8%

Accounts Receivable

$5.01K

-43.6%

Inventory

$10.78K

-31.7%

Long Term Debt

$629.29K

-0.9%

Short Term Debt

$80.00K

+0.0%

Return on Assets

-14.12%

N/A

Return on Invested Capital

12.39%

N/A

Free Cash Flow

$5.96K

+125.9%

Operating Cash Flow

$5.96K

+125.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ESMCEscalon Medical Corp.
$0.18-12.50%
PHMBPharmaCom BioVet, Inc.
$0.00+0.00%
TBIOTelesis Bio, Inc.
$0.00+10.00%
EDXCEndexx Corporation
$0.00+9900.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.28+0.11%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.22-0.03%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$45.95+0.03%
BMNRBitmine Immersion Technologies
$17.65+0.12%

Questions About CYDX

What is the current price of CYduct Diagnostics?

CYduct Diagnostics is trading at $2.70 per share.

What is the 52-week range for CYduct Diagnostics?

Over the past 52 weeks, CYduct Diagnostics has traded between $0.20 and $2.90.

How much debt does CYduct Diagnostics have?

As of the most recent reporting period, CYduct Diagnostics reported total debt of $709.29K.

How much cash does CYduct Diagnostics have on hand?

CYduct Diagnostics reported $8.98K in cash and cash equivalents in its most recent financial results.

What is CYduct Diagnostics’s dividend yield?

CYduct Diagnostics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services